Clover Biopharmaceuticals (HKSE:02197) Days Payable : 2,921.39 (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Clover Biopharmaceuticals Days Payable?

Clover Biopharmaceuticals's average Accounts Payable for the six months ended in Dec. 2023 was HK$259.34 Mil. Clover Biopharmaceuticals's Cost of Goods Sold for the six months ended in Dec. 2023 was HK$16.20 Mil. Hence, Clover Biopharmaceuticals's Days Payable for the six months ended in Dec. 2023 was 2,921.39.

The historical rank and industry rank for Clover Biopharmaceuticals's Days Payable or its related term are showing as below:

HKSE:02197' s Days Payable Range Over the Past 10 Years
Min: 10932.83 Med: 13647.54 Max: 13647.54
Current: 10932.83

During the past 5 years, Clover Biopharmaceuticals's highest Days Payable was 13647.54. The lowest was 10932.83. And the median was 13647.54.

HKSE:02197's Days Payable is ranked better than
95.29% of 722 companies
in the Biotechnology industry
Industry Median: 148.145 vs HKSE:02197: 10932.83

Clover Biopharmaceuticals's Days Payable increased from Dec. 2022 (0.00) to Dec. 2023 (2,921.39). It may suggest that Clover Biopharmaceuticals delayed paying its suppliers.

Clover Biopharmaceuticals Days Payable Historical Data

The historical data trend for Clover Biopharmaceuticals's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Clover Biopharmaceuticals Days Payable Chart

Clover Biopharmaceuticals Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Days Payable

13,647.54

Clover Biopharmaceuticals Semi-Annual Data
	Dec19	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Days Payable	Get a 7-Day Free Trial			-	-	-	497,371.13	2,921.39

Competitive Comparison of Clover Biopharmaceuticals's Days Payable

For the Biotechnology subindustry, Clover Biopharmaceuticals's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Clover Biopharmaceuticals's Days Payable Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Clover Biopharmaceuticals's Days Payable distribution charts can be found below:

* The bar in red indicates where Clover Biopharmaceuticals's Days Payable falls into.

Clover Biopharmaceuticals Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Clover Biopharmaceuticals's Days Payable for the fiscal year that ended in Dec. 2023 is calculated as

	Days Payable (A: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2022 )	+	Accounts Payable (A: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2023 )	*	Days in Period
=	( (956.984	+	271.07)	/	2 )	/	16.422	*	365
=	614.027					/	16.422	*	365
=	13,647.54

Clover Biopharmaceuticals's Days Payable for the quarter that ended in Dec. 2023 is calculated as:

	Days Payable (Q: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Jun. 2023 )	+	Accounts Payable (Q: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (Q: Dec. 2023 )	*	Days in Period
=	( (247.608	+	271.07)	/	2 )	/	16.201	*	365 / 2
=	259.339					/	16.201	*	365 / 2
=	2,921.39

Clover Biopharmaceuticals Days Payable Related Terms

Thank you for viewing the detailed overview of Clover Biopharmaceuticals's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Clover Biopharmaceuticals (HKSE:02197) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Clover Biopharmaceuticals Ltd (HKSE:02197) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

N/A

Address

1598-1601 West Nanjing Road, 49th Floor, Park Place, Jing’an District, Shanghai, CHN

Website

https://www.cloverbiopharma.com

Clover Biopharmaceuticals Ltd is a clinical-stage biotechnology company committed to developing novel vaccines and biologic therapeutic candidates for infectious diseases as well as cancer and autoimmune diseases.

Executives

Liang Peng	2101 Beneficial owner
Liang Joshua G	2501 Other
Jpmorgan Chase & Co.	2201 Interest of corporation controlled by you
Hillhouse Investment Management, Ltd.	2102 Investment manager
Aut-xxi Investment Holdings Limited	2201 Interest of corporation controlled by you
Jnry V Holdings Limited	2101 Beneficial owner
Aut-xxi Hk Holdings Limited	2101 Beneficial owner
Aut-xxi Holdings Limited	2201 Interest of corporation controlled by you
Hh Imv Holdings, L.p.	2201 Interest of corporation controlled by you
Hillhouse Fund Iv, L.p.	2201 Interest of corporation controlled by you
Temasek Holdings (private) Limited	2201 Interest of corporation controlled by you
The Core Trust Company Limited	2301 Trustee
Tct (bvi) Limited	2501 Other
Super Novel International Limited	2306 Nominee for another person
Shang Hai Tian He Sheng Tai Qi Ye Guan Li He Huo Qi Ye You Xian He Huo

Clover Biopharmaceuticals (HKSE:02197) Headlines

No Headlines